Trader consensus heavily favors no new COVID variant of concern before 2027 at 92.5% implied probability because circulating SARS-CoV-2 lineages remain Omicron descendants like XFG and NB.1.8.1, classified only as variants under monitoring with no evidence of meaningfully higher severity or immune escape that would trigger official reclassification. Widespread hybrid immunity from prior infections and updated 2025-2026 vaccines targeting JN.1-lineage strains such as LP.8.1 or XFG has kept hospitalizations low and stable. Surveillance through wastewater, sequencing, and traveler data shows continued subvariant churn without a fitness leap comparable to earlier shifts, while the brief remaining window to year-end further limits the scope for sudden escalation.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoNew COVID variant of concern before 2027?
New COVID variant of concern before 2027?
$245,380 Wol.
$245,380 Wol.
$245,380 Wol.
$245,380 Wol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Rynek otwarty: Dec 1, 2025, 4:49 PM ET
Rozstrzygający
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Rozstrzygający
0x65070BE91...Trader consensus heavily favors no new COVID variant of concern before 2027 at 92.5% implied probability because circulating SARS-CoV-2 lineages remain Omicron descendants like XFG and NB.1.8.1, classified only as variants under monitoring with no evidence of meaningfully higher severity or immune escape that would trigger official reclassification. Widespread hybrid immunity from prior infections and updated 2025-2026 vaccines targeting JN.1-lineage strains such as LP.8.1 or XFG has kept hospitalizations low and stable. Surveillance through wastewater, sequencing, and traveler data shows continued subvariant churn without a fitness leap comparable to earlier shifts, while the brief remaining window to year-end further limits the scope for sudden escalation.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania